It is worth noting that the CLDN18-ARHGAP gene fusion occurred in 9% (8/87) of GC patients and 19% (5/26) of poorly cohesive GC patients, which type with the worst prognosis. The gene discussed is CLDN18; the disease is gastric cancer.